TD-165
N/A
Report date: 2022/12/29 15:53:18
NME
Base Information
Drug NameTD-165
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Research Institute Of Bioscience And Biotechnology
China Registration ClassN/A
Develop Information
Active CompaniesKorea Research Institute Of Bioscience And Biotechnology
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A